Skip to Content


In the US, Azacitidine (azacitidine systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Myelodysplastic Syndrome.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


Cytostatic agent

Chemical Name

4-amino-1-β-D-ribofuranosyl-s-triazin-2(1H)-one (WHO)

Foreign Names

  • Azacitidinum (Latin)
  • Azacitidin (German)
  • Azacitidine (French)
  • Azacitidina (Spanish)

Generic Names

  • Azacitidine (OS: USAN, BAN, JAN)
  • 5-AC (IS)
  • 5-AZCR (IS)
  • BRN 0620461 (IS)
  • Ladakamycin (IS)
  • U 18496 (IS)
  • UNII-M801H13NRU (IS)
  • WR-183027 (IS)

Brand Names

  • Iterbil
    Tuteur, Argentina
  • Mielozitidina
    Laboratorio LKM, Vietnam; LKM, Argentina
  • Tazadir
    Aspen, Argentina
  • Vidaza
    Celgene, Austria; Celgene, Australia; Celgene, Belgium; Celgene, Switzerland; Celgene, Czech Republic; Celgene, Germany; Celgene, Denmark; Celgene, Spain; Celgene, Hong Kong; Celgene, Hungary; Celgene, Ireland; Celgene, Israel; Celgene, Iceland; Celgene, Italy; Celgene, Lithuania; Celgene, Netherlands; Celgene, Norway; Celgene, New Zealand; Celgene, Portugal; Celgene, Romania; Celgene, Russian Federation; Celgene, Sweden; Celgene, Thailand; Celgene Europe, Greece; Celgene Europe, Slovenia; Celgene Limited, Tunisia; Er-Kim, Turkey; Invida, Thailand; Key Oncologics, South Africa; Medical Intertrade, Croatia (Hrvatska); Nippon Shinyaku, Japan; Purzer, Taiwan; Tecnofarma, Chile; Tecnofarma, Colombia; Varifarma, Argentina

International Drug Name Search


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.